Yi Cao

2.9k total citations · 1 hit paper
82 papers, 2.0k citations indexed

About

Yi Cao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yi Cao has authored 82 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 24 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Yi Cao's work include Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (15 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Yi Cao is often cited by papers focused on Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (15 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Yi Cao collaborates with scholars based in China, France and United States. Yi Cao's co-authors include Zhengrong Li, Yu‐Ming Chen, Gai Ayalon, William J. Meilandt, Melanie A. Huntley, Matthew H. Bailey, Karpagam Srinivasan, Zora Modrušan, Hai Ngu and Patrick C. G. Haddick and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Scientific Reports.

In The Last Decade

Yi Cao

77 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer’s Disease Not Evident in Mouse Models

2018 445 citations Yi Cao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Cao China	26	1.1k	632	394	379	223	82	2.0k
Jena J. Steinle United States	30	1.5k 1.4×	337 0.5×	347 0.9×	265 0.7×	264 1.2×	125	2.9k
Hao Guo China	29	1.1k 1.1×	617 1.0×	149 0.4×	210 0.6×	127 0.6×	73	2.0k
Chi Dae Kim South Korea	26	811 0.8×	248 0.4×	364 0.9×	192 0.5×	297 1.3×	74	2.0k
Tianlun Yang China	28	1.4k 1.4×	554 0.9×	411 1.0×	82 0.2×	338 1.5×	128	2.6k
Li Pang China	20	736 0.7×	246 0.4×	346 0.9×	214 0.6×	96 0.4×	63	1.6k
Jian‐Xiong Chen United States	33	1.2k 1.1×	475 0.8×	221 0.6×	139 0.4×	479 2.1×	94	2.7k
Jun‐Yang Liou Taiwan	31	1.6k 1.5×	321 0.5×	219 0.6×	100 0.3×	181 0.8×	68	2.5k
Tatsuki Itoh Japan	32	1.1k 1.0×	532 0.8×	193 0.5×	170 0.4×	133 0.6×	81	2.4k
Heng Cai China	32	1.7k 1.6×	1.2k 1.9×	131 0.3×	173 0.5×	133 0.6×	85	2.7k

Countries citing papers authored by Yi Cao

Since Specialization

Citations

This map shows the geographic impact of Yi Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Cao more than expected).

Fields of papers citing papers by Yi Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Cao. The network helps show where Yi Cao may publish in the future.

Co-authorship network of co-authors of Yi Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Cao. A scholar is included among the top collaborators of Yi Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Cao. Yi Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Tingting, Jinbo Chen, Xin Zhang, et al.. (2025). A machine learning model for predicting the risk of diabetic nephropathy in individuals with type 2 diabetes mellitus. Frontiers in Endocrinology. 16. 1587932–1587932. 1 indexed citations

Wang, Guosen, Yi Cao, Zhihong Cai, et al.. (2025). A Mutual Interaction Between GSTP1 and p53 Improves the Drug Resistance and Malignant Biology of Pancreatic Cancer. Cancer Science. 116(5). 1268–1281. 1 indexed citations

Zhou, Xiaowei, Huaming Zhu, Huihui Xu, et al.. (2025). Cell-free fat extract improves embryo development and clinical outcomes in older women with previous in-vitro fertilization failure. Reproductive Biology and Endocrinology. 23(1). 8–8.

Xu, Lixing, et al.. (2025). Artificial intelligence in magnetic resonance imaging for predicting lymph node metastasis in rectal cancer patients: a meta-analysis. European Radiology. 35(10). 6193–6206.

Wang, Shuo, et al.. (2024). Construction of charge-reversible coordination-crosslinked spherical nucleic acids to deliver dual anti-cancer genes and ferroptosis payloads. International Journal of Biological Macromolecules. 277(Pt 4). 134515–134515. 1 indexed citations

Su, Ning, Yi Cao, Yi Xia, et al.. (2023). Anlotinib as a third-line or further treatment for recurrent or metastatic nasopharyngeal carcinoma: a single-arm, phase 2 clinical trial. BMC Medicine. 21(1). 423–423. 8 indexed citations

Wu, Yukang, Yi Cao, Jianbo Xiong, et al.. (2022). Comprehensive Analysis of Immune Infiltrates of Ferroptosis-Related Long Noncoding RNA and Prediction of Colon Cancer Patient Prognoses. Journal of Immunology Research. 2022. 1–16. 24 indexed citations

Yan, Qing, Haoming Lin, Ke Zhu, et al.. (2022). Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma. Frontiers in Oncology. 12. 810269–810269. 21 indexed citations

Yan, Yan, et al.. (2022). Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy. Biomedicine & Pharmacotherapy. 156. 113790–113790. 14 indexed citations

10.

Chen, Wenzheng, Jianfeng Huang, Jianbo Xiong, et al.. (2021). Identification of a Tumor Microenvironment‐Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer. Oxidative Medicine and Cellular Longevity. 2021(1). 6290261–6290261. 33 indexed citations

11.

Chen, Changyu, Qiang Zheng, Wenzheng Chen, et al.. (2021). The RNA-Binding Protein NELFE Promotes Gastric Cancer Growth and Metastasis Through E2F2. Frontiers in Oncology. 11. 677111–677111. 11 indexed citations

12.

Xiong, Jianbo, Yi Tu, Daojiang Li, et al.. (2019). <p>Epigenetics mechanisms mediate the miR-125a/BRMS1 axis to regulate invasion and metastasis in gastric cancer</p>. OncoTargets and Therapy. Volume 12. 7513–7525. 7 indexed citations

13.

Xiong, Jianbo, Zhengrong Li, Tao Zhong, et al.. (2019). Overexpression of TWA1 predicts poor prognosis in patients with gastric cancer. Pathology - Research and Practice. 215(11). 152594–152594. 7 indexed citations

14.

Wu, Di, Binyao Yang, Jiansong Chen, et al.. (2018). Upregulation of long non-coding RNA RAB1A-2 induces FGF1 expression worsening lung cancer prognosis. Cancer Letters. 438. 116–125. 34 indexed citations

15.

Gong, Wei, Yi Cao, Yuanyuan Wang, et al.. (2018). Upregulation of LncRNA FEZF-AS1 is associated with advanced clinical stages and family history of cancer in patients with NSCLC. Pathology - Research and Practice. 214(6). 857–861. 12 indexed citations

16.

Yang, Lei, Di Wu, Jinbin Chen, et al.. (2017). A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese. Carcinogenesis. 39(3). 347–359. 17 indexed citations

17.

Cao, Yi, et al.. (2015). Greater serum carotenoid levels associated with lower prevalence of nonalcoholic fatty liver disease in Chinese adults. Scientific Reports. 5(1). 12951–12951. 44 indexed citations

18.

Zhu, Jie, et al.. (2013). The Influence of g.19124G>A Genetic Polymorphism in the OPG Gene on Bone Mineral Density in Chinese Women. Genetic Testing and Molecular Biomarkers. 17(9). 696–699. 1 indexed citations

19.

Guo, Zhenghui, Hai Huang, Tao Du, et al.. (2010). [Inhibition and significance of pigment epithelium-derived factor in the development and metastasis of prostate cancer].. PubMed. 90(42). 2980–3. 3 indexed citations

20.

Guo, Zhenghui, Hai Huang, Lexiang Zeng, et al.. (2010). Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells. Medical Oncology. 28(3). 878–887. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact